New drugs, new challenges for dermatologists: mucocutaneous ulcers secondary to everolimus

Everolimus, a mammalian target of rapamycin inhibitor, is an emerging drug, which is being increasingly applied in oncology and solid organ transplantation. Oral ulcers are a frequent side effect associated with this immunosupressor. We report the case of a renal transplant recipient who developed d...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasin, Victor Pavan, Pereira, Amanda Regio, de Carvalho, Kalline Andrade, de Paiva, João Marcos Góes, Enokihara, Milvia Maria Simões e Silva, Porro, Adriana Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Dermatologia 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540539/
https://www.ncbi.nlm.nih.gov/pubmed/26312705
http://dx.doi.org/10.1590/abd1806-4841.20153672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540539/
https://www.ncbi.nlm.nih.gov/pubmed/26312705
http://dx.doi.org/10.1590/abd1806-4841.20153672

Ejemplares similares